question is : so how many on the trial ended up dying? normal survival is 5.5 months
- Forums
- ASX - By Stock
- ATX
- Ann: Update on ACCENT Trial in Pancreatic Cancer
ATX
amplia therapeutics limited
Add to My Watchlist
7.14%
!
18.8¢

Ann: Update on ACCENT Trial in Pancreatic Cancer, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
18.8¢ |
Change
0.013(7.14%) |
Mkt cap ! $91.21M |
Open | High | Low | Value | Volume |
18.0¢ | 19.0¢ | 17.0¢ | $1.442M | 7.917M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 345191 | 18.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
19.0¢ | 980387 | 31 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 311191 | 0.185 |
24 | 1149222 | 0.180 |
28 | 1450240 | 0.175 |
38 | 2939190 | 0.170 |
12 | 1573627 | 0.165 |
Price($) | Vol. | No. |
---|---|---|
0.190 | 1082597 | 31 |
0.195 | 786070 | 18 |
0.200 | 708416 | 13 |
0.205 | 535723 | 11 |
0.210 | 260233 | 5 |
Last trade - 14.11pm 07/08/2025 (20 minute delay) ? |
Featured News
ATX (ASX) Chart |